In the Northeast, where the average retail cost of GLP-1 medications exceeds $1450/month, Tirzepatide through Weight Method starts at just $349/month. For New Rochelle residents, this means access to a medication shown to produce 20-25% of body weight average body weight reduction without the specialist wait times or surprise bills common in the region.
FDA-approved Tirzepatide prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · New Rochelle is already seeing results
Tirzepatide in New Rochelle, NY: an FDA-approved GLP-1 medication shown to achieve 15-22% body weight loss in clinical trials. Weight Method offers Tirzepatide to patients in New Rochelle from $349/month with virtual consultations and direct-to-door shipping.
Tirzepatide (Mounjaro / Zepbound) works by mimicking incretin hormones that your body naturally produces after eating. It activates receptors in the brain that regulate hunger and satiety, reducing appetite and helping you feel full with smaller portions. For New Rochelle residents, Weight Method makes this treatment accessible through telehealth — a virtual consultation with a licensed provider, your prescription shipped to your door, and ongoing clinical support. Clinical trials demonstrate an average weight loss of 20-25% of body weight of body weight, making Tirzepatide one of the most effective FDA-approved options for chronic weight management.
Hispanic adults in New Rochelle face disproportionately high rates of obesity and type 2 diabetes, conditions that Tirzepatide is specifically designed to treat. Weight Method removes the barriers that have historically limited access — language, cost, and insurance requirements. Our platform is fully bilingual, Tirzepatide starts at $349/month with no insurance needed, and everything happens virtually from your New Rochelle home.
Clinically proven GLP-1 medications at transparent prices

Same active ingredient as Ozempic® & Wegovy®. Proven to reduce body weight by up to 15%.

Same active ingredient as Mounjaro® & Zepbound®. Dual-action GLP-1/GIP for enhanced results.
Consult with a licensed provider in New York and start Tirzepatide from $349/month.
Get Started NowFree consultation. No commitment.